<DOC>
	<DOCNO>NCT00909558</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness natural killer ( NK ) cell natural killer T ( NKT ) cell-based autologous adoptive immunotherapy subject metastatic , treatment-refractory breast cancer , glioma , hepatocellular carcinoma , squamous cell lung cancer , pancreatic cancer , colon cancer prostate cancer .</brief_summary>
	<brief_title>Safety Effectiveness Study Autologous Natural Killer Natural Killer T Cells Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Male female le 18 year age 80 year age . Life expectancy ≥ 24 week measure Eastern Cooperative Oncology Group ( ECOG ) performance status . Subjects must present one follow disease pathology : Breast Cancer , Glioma , Hepatocellular Cancer , Squamous Cell Lung Cancer , Pancreatic Cancer , Colon Cancer Prostate Cancer The pathology must assessable disease ( measurable CT scan MRI ) refractory standard treatment ( e.g. , chemotherapy , radiation , etc . ) Negative hepatitis B , hepatitis C , HIV , CMV . Subjects must present leukocyte count 3,000/μL platelet count 100,000/ μL . Subjects must present minimum hemoglobin level 10 . If female , subject surgically sterile ( hysterectomy , bilateral tubal ligation , bilateral oophorectomy ) , post menopausal ( menses &gt; 12 month ) , use highefficiency method contraception implant , injectable , combination oral contraceptive , intrauterine device ( IUD ) sexual abstinence , vasectomized partner . If female childbearing potential , subject pregnant , breastfeed plan pregnancy study , negative pregnancy test screen visit . Able comprehend sign inform consent document comply requirement study . No measurable malignant disease CT scan tumor marker . Life expectancy ≤ 24 week measure Eastern Cooperative Oncology Group ( ECOG ) performance status . Age le 18 year 80 year age . Documented/confirmed positive test hepatitis B , hepatitis C , HIV , CMV . Prior current history autoimmune disease . Pregnant lactating woman . Leukocyte count &lt; 3,000 /μL prior leukapheresis . Platelet count &lt; 100,000/μL prior leukapheresis . Hemoglobin level 10 . PTT ( prothrombin time ) &lt; 12 second &gt; 15 second . aPTT ( activate partial thromboplastin time ) &lt; 25 second &gt; 39 second . Failure refusal sign inform consent study . Culture fail meet specification study . Subject medical condition , opinion investigator , might significantly affect ability safely participate study affect conduct study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>metastatic malignancy</keyword>
	<keyword>tumor marker</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>cancer</keyword>
	<keyword>breast cancer</keyword>
	<keyword>glioma</keyword>
	<keyword>hepatocellular cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>colon cancer</keyword>
	<keyword>prostate cancer</keyword>
</DOC>